A Double Blind, Randomized Placebo Controlled Clinical Trial Investigating the Efficacy and Safety of Somatuline Depot (Lanreotide) Injection in the Treatment of Carcinoid Syndrome
收藏DataCite Commons2025-06-01 更新2026-05-07 收录
下载链接：
https://search.vivli.org/doiLanding/studies/PR00008353/isLanding
下载链接
链接失效反馈官方服务：
资源简介：
The purpose of this study was to determine whether monthly deep subcutaneous (s.c.)
injections of lanreotide Autogel (Somatuline Depot) were effective and safe in controlling
diarrhoea and flushing by reducing the usage of s.c. short-acting octreotide as a rescue
medication to control symptoms in subjects with carcinoid syndrome.
提供机构：
Vivli
创建时间：
2022-08-16
